Log In
BCIQ
Print this Print this
 

ATB-340

  Manage Alerts
Collapse Summary General Information
Company Antibe Therapeutics Inc.
DescriptionGI-safe derivative of aspirin
Molecular Target
Mechanism of ActionNSAID
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationBleeding
Indication DetailsTreat clotting disorders
Regulatory Designation
PartnerKnight Therapeutics Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

2

0

0

$20.0M


 Deals Details
Get a free BioCentury trial today